Type 1 Diabetes Education and Support Study

Description

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Conditions

Type1diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Evaluating the Feasibility of Type 1 Diabetes Education and Support Intervention to Improve Diabetes Distress Among Black Young Adults

Type 1 Diabetes Education and Support Study

Condition
Type1diabetes
Intervention / Treatment

-

Contacts and Locations

Atlanta

Kaiser Permanente Georgia, Atlanta, Georgia, United States, 30309

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Kaiser Permanente Georgia Member
  • * Aged 18 - 30 years
  • * Confirmed diagnosis of Type 1 diabetes
  • * Hemoglobin A1c \> 7.5 at time of enrollment
  • * a cell phone able to send/receive text messages
  • * Self-reported race of Black or African American
  • * Ability to read in English and provide informed consent
  • * Developmental delay or other cognitive impairment that would render the participant unable to provide informed consent
  • * Subjects with visual impairment or have severe hearing or other physical disabilities that would be a barrier for participating in-group or web sessions
  • * Diabetes complications that would preclude participation in the study

Ages Eligible for Study

18 Years to 30 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Kaiser Permanente,

Teaniese L Davis, PhD, MPH, PRINCIPAL_INVESTIGATOR, Principal Investigator

Study Record Dates

2026-03